Mode
Text Size
Log in / Sign up
N/A N=850 Randomized Single-blind Health Services Research

Pain Program for Active Coping & Training

Chronic Non-malignant Pain

Enrolled (actual)
850
Serious AEs
24.2%
Results posted
May 2022
Primary outcome: Primary: Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS") — 6.485; 6.645; 5.486; 6.210 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Interdisciplinary pain program (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Kaiser Permanente
Primary completion
Feb 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS")
6.485; 6.645; 5.486; 6.210; 5.516; 6.197
SECONDARY
Pain-related Disability
0.672; 0.692; 0.612; 0.675; 0.609; 0.678
SECONDARY
Average Daily Dose of Opioids
47.458; 55.252; 46.641; 56.695; 45.606; 55.563
SECONDARY
Patient Satisfaction
4.263; 4.237; 4.240; 3.984; 3.658; 3.581
SECONDARY
Health Care Costs
21,372; 25,648; 9,395; 11,343
SECONDARY
Count of Health Care Encounters by Type (Health Care Utilization)
20.85; 21.59; 10.42; 10.11; 24.04; 23.18
SECONDARY
Inpatient Hospital Days (Health Care Utilization)
0.86; 0.22
SECONDARY
Total Pharmacy Dispenses (Health Care Utilization)
50.45; 52.22

Summary

The overall aim of this study is to adopt an integrative rehabilitation approach for helping patients adopt self-management skills for managing chronic pain, limiting use of opioid medications, and identifying exacerbating factors amenable to treatment (e.g., depression, sleep problems) that is feasible and sustainable within the primary care setting.

Eligibility Criteria

Patient inclusion criteria are:

  • Adult (18 years of age or older) Kaiser Permanente (KP) health plan members from the KP Northwest, KP Georgia, and KP Hawaii regions who receive their primary care services from participating primary care providers
  • Kaiser Permanente health plan membership of at least 180 days duration
  • Long term opioid use defined by: 90+ day supply of short acting opioid spanning at least 120 days or 2 or more long acting opioid dispense in the past 180 days
  • Pain diagnosis within the past year (based on ICD-9 or ICD-10 diagnostic codes)
  • English speaking

Patient exclusion criteria are:

  • Currently enrolled in intensive addiction medicine services or evidence of active substance dependence
  • Cognitive impairment severe enough to preclude patient's participation in a behavioral/lifestyle change program
  • Current malignant cancer diagnosis
  • Having received hospice or other end-of-life palliative care within past year
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02113592). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search